Recognition and management of acute and chronic hepatic encephalopathy.
D000208:Acute Disease; D000588:Amines / Q000378:metabolism; D000641:Ammonia / Q000009:adverse effects / Q000097:blood; D000818:Animals; D001929:Brain Edema / Q000150:complications; D002490:Central Nervous System / Q000503:physiopathology; D002908:Chronic Disease; D004035:Diet Therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005078:Exchange Transfusion, Whole Blood; D005232:Fatty Acids, Volatile / Q000009:adverse effects; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis
D000588:Amines; D005232:Fatty Acids, Volatile; D007792:Lactulose; D004295:Dihydroxyphenylalanine; D000641:Ammonia; D009355:Neomycin